Funding
Turn ideas into impact
Show Me
Due: October 20, 2027
Innovation Grants to Nurture Initial Translational Efforts (IGNITE): Neurotherapeutic Agent Characterization and In vivo Efficacy Studies (R61/R33 Clinical Trial Not Allowed)
Type
Grant
Source
Federal
Opp Number
PAR-25-225
Due: October 25, 2027
National Cooperative Drug/Device Discovery/Development Groups (NCDDG) for the Treatment of Mental Disorders (U19 Clinical Trial Optional)
Type
Cooperative Agreement
Source
Federal
Opp Number
PAR-25-353
Due: October 25, 2027
National Cooperative Drug/Device Discovery/Development Groups (NCDDG) for the Treatment of Mental Disorders (U01 Clinical Trial Optional)
Type
Cooperative Agreement
Source
Federal
Opp Number
PAR-25-352
Due: October 25, 2027
New
Research Enhancement Award Program (REAP) for Health Professional Schools and Graduate Schools (R15 Clinical Trial Required)
US $375,000
Type
Grant
Source
Federal
Opp Number
PAR-27-078
Due: October 25, 2027
Cancer Prevention and Control Clinical Trials Planning Grant Program(R34 Clinical Trials Optional)
US $600,000
Type
Grant
Source
Federal
Due: October 25, 2027
Cancer Prevention and Control Clinical Trials Planning Grant Program (U34 Clinical Trials Optional)
US $600,000
Type
Grant
Source
Federal
Due: October 25, 2027
Cancer Prevention and Control Clinical Trials Planning Grant Program (U34 Clinical Trials Optional)
Type
Cooperative Agreement
Source
Federal
Opp Number
PAR-25-103
Due: October 25, 2027
Cancer Prevention and Control Clinical Trials Planning Grant Program (R34 Clinical Trials Optional)
Type
Grant
Source
Federal
Opp Number
PAR-25-104
Due: November 5, 2027
Limited Competition: Renewal of Existing NINDS-Supported Clinical Trial Cooperative Agreement Awards (U01 – Clinical Trials Required)
Type
Cooperative Agreement
Source
Federal
Opp Number
PAR-25-149
Submit your funding opportunity.
Do you have a grant, incentive, funding competition, or other funding source to share?